Ling Gong

First People’s Hospital of Zunyi, Zunyi Medical University

Ling Gong's research contributions span multiple fields, including immunology, infectious diseases, and metabolic disorders. Their work identifies independent HLA associations in autoimmune hepatitis type 1, maps the clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases, and sheds light on the Jak/Syk pathway in promoting Th17 responses in psoriasis. Additionally, Gong's research investigates the role of thymic stromal lymphopoietin in activating dendritic cells, explores gene prediction models for idiopathic pulmonary fibrosis, and examines the efficacy of bisphosphonates in treating atherosclerosis and vascular calcification. Furthermore, their studies focus on the relationship between sleep behaviors and body composition in adolescents, the stimulation of liver fibrosis by N2 neutrophils, and the outcomes of microwave ablation versus radiofrequency ablation for patients with primary and secondary hyperparathyroidism. Gong's research also explores immunosuppressive medication nonadherence in kidney transplant recipients, respiratory syncytial virus and influenza virus infections, metabolic dysfunction-associated fatty liver disease, and the impact of methimazole treatment on children and adolescents with Graves' disease.